IGC Pharma's total assets for Q2 2026 were $9.74M, an increase of 22.66% from the previous quarter. IGC total liabilities were $1.65M for the fiscal quarter, a -11.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.